Literature DB >> 11583977

Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice.

K L Gabrielson1, B A Hogue, V A Bohr, A J Cardounel, W Nakajima, J Kofler, J L Zweier, E R Rodriguez, L J Martin, N C de Souza-Pinto, J Bressler.   

Abstract

We investigated the effects of 3-nitropropionic acid (3NPA), a previously characterized neurotoxin, in four strains of mice to better understand the molecular basis of variable host responses to this agent. Unexpectedly, we found significant cardiac toxicity that always accompanied the neurotoxicity in all strains of mice in acute and subacute/chronic toxicity testing. Caudate putamen infarction never occurred without cardiac toxicity. All mouse strains tested are sensitive to 3NPA although the C57BL/6 and BALB/c mice require more exposure than 129SVEMS and FVB/n mice. Cardiac toxicity alone was found in 50% of symptomatic mice tested and morphologically, the cardiac toxicity is characterized by diffuse swelling of cardiomyocytes and multifocal coagulative contraction band necrosis. In subacute to chronic exposure, atrial thrombosis, cardiac mineralization, cell loss, and fibrosis are combined with cardiomyocyte swelling and necrosis. Ultrastructurally, mitochondrial swelling occurs initially, followed by disruption of myofilaments. Biochemically, isolated heart mitochondria from the highly sensitive 129SVEMS mice have a significant reduction of succinate dehydrogenase activity, succinate oxygen consumption rates, and heart adenosine triphosphate after 3NPA treatment. The severity of morphological changes parallels the biochemical alterations caused by 3NPA, consistent with cardiac toxicity being a consequence of the effects of 3NPA on succinate dehydrogenase. These experiments show, for the first time, that 3NPA has important cardiotoxic effects as well as neurotoxic effects, and that cardiac toxicity possibly resulting from inhibition of the succinate dehydrogenase in heart mitochondria, contributes to the cause of death in 3NPA poisoning in acute and subacute/chronic studies in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583977      PMCID: PMC1850498          DOI: 10.1016/S0002-9440(10)62536-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  89 in total

Review 1.  3-Nitropropionic acid animal model and Huntington's disease.

Authors:  C V Borlongan; T K Koutouzis; P R Sanberg
Journal:  Neurosci Biobehav Rev       Date:  1997-05       Impact factor: 8.989

2.  Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.

Authors:  M C Guyot; P Hantraye; R Dolan; S Palfi; M Maziére; E Brouillet
Journal:  Neuroscience       Date:  1997-07       Impact factor: 3.590

3.  Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical.

Authors:  J H Doroshow; K J Davies
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

4.  Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age.

Authors:  R G Hansford; B A Hogue; V Mildaziene
Journal:  J Bioenerg Biomembr       Date:  1997-02       Impact factor: 2.945

5.  Unilateral hypoxic-ischemic injury in neonatal rat results in a persistent increase in the density of striatal tyrosine hydroxylase immunoperoxidase staining.

Authors:  R E Burke; J Kent; N Kenyon; A Karanas
Journal:  Brain Res Dev Brain Res       Date:  1991-02-22

6.  Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum.

Authors:  J R Simpson; O Isacson
Journal:  Exp Neurol       Date:  1993-05       Impact factor: 5.330

7.  Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.

Authors:  M F Beal; D R Henshaw; B G Jenkins; B R Rosen; J B Schulz
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

8.  Cocaine-induced mitochondrial dysfunction in primary cultures of rat cardiomyocytes.

Authors:  C Yuan; D Acosta
Journal:  Toxicology       Date:  1996-08-01       Impact factor: 4.221

9.  Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum.

Authors:  Y Uemura; N W Kowall; M F Beal
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

10.  The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.

Authors:  M Arellano; M Malet-Martino; R Martino; P Gires
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  17 in total

1.  Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Authors:  Marcus J Calkins; Rebekah J Jakel; Delinda A Johnson; Kaimin Chan; Yuet Wai Kan; Jeffrey A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.

Authors:  Aleksandra Milutinović; Ruda Zorc-Pleskovič
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

3.  Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells.

Authors:  Attila Bacsi; Mitchell Woodberry; William Widger; John Papaconstantinou; Sankar Mitra; Johnny W Peterson; Istvan Boldogh
Journal:  Mitochondrion       Date:  2006-08-03       Impact factor: 4.160

4.  Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle.

Authors:  Elizabeth Hernández-Echeagaray; Nancy González; Angélica Ruelas; Ernesto Mendoza; Erika Rodríguez-Martínez; Rafael Antuna-Bizarro
Journal:  Neurol Sci       Date:  2010-08-24       Impact factor: 3.307

5.  Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

Authors:  Marcus J Calkins; Jessica A Townsend; Delinda A Johnson; Jeffrey A Johnson
Journal:  Exp Neurol       Date:  2010-04-18       Impact factor: 5.330

6.  Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.

Authors:  Michael J Mihm; Deborah M Amann; Brandon L Schanbacher; Ruth A Altschuld; John Anthony Bauer; Kari R Hoyt
Journal:  Neurobiol Dis       Date:  2006-11-27       Impact factor: 5.996

7.  ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.

Authors:  Frances Belmonte; Samarjit Das; Polina Sysa-Shah; Vidhya Sivakumaran; Brian Stanley; Xin Guo; Nazareno Paolocci; Miguel A Aon; Masaki Nagane; Periannan Kuppusamy; Charles Steenbergen; Kathleen Gabrielson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

8.  Detection of 3-nitropropionic acid and cytotoxicity inMucor circinelloides.

Authors:  M Hollmann; E Razzazi-Fazeli; J Grajewski; M Twaruzek; M Sulyok; J Böhm
Journal:  Mycotoxin Res       Date:  2008-09       Impact factor: 3.833

Review 9.  Mouse models of Huntington's disease and methodological considerations for therapeutic trials.

Authors:  Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2009-04-10

10.  Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.

Authors:  Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.